Women who have received HPV vaccine are recommended to undergo cervical screening according to current guidelines.11

Vaccination is a preventive measure, complementary to cervical screening, and vice versa. HPV types other than those included in the current vaccines can cause cervical cancer. Therefore, both cervical screening and HPV vaccination are recommended.

Women aged 25–70 years are recommended to have HPV testing every 5 years, with exit testing at 70–74 years.

For women who have recently been diagnosed with cervical dysplasia or HPV infection, or have been treated for this in the past, HPV vaccine will not affect current disease. However, HPV vaccination may be warranted, because it can prevent:12

  • future infection or disease due to reinfection
  • spread of current infection
  • infection due to different HPV types included in the vaccine 

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018